HOUSE_OVERSIGHT_024029.jpg
2.59 MB
Extraction Summary
2
People
7
Organizations
1
Locations
0
Events
1
Relationships
3
Quotes
Document Information
Type:
Investment report / private placement memorandum (confidential)
File Size:
2.59 MB
Summary
This document is page 18 of a confidential report, likely a Private Placement Memorandum or due diligence report, bearing a House Oversight Committee stamp. It details the historical investment performance of the 'New Leaf team' (associated with NLV-I and NLV-II funds) and their previous management of 'Sprout Capital' funds. The text highlights a track record of investing over $1.67 billion in healthcare technology since 1995, generating over $2.6 billion in gross realizations and outperforming major financial indices like the S&P 500 and NASDAQ.
People (2)
| Name | Role | Context |
|---|---|---|
| The Fund Managers | Investment Managers |
Managers of the healthcare technology portfolios described in the document.
|
| The New Leaf team | Investment Team |
Identified as the team that invested over $1.67 billion since 1995.
|
Locations (1)
| Location | Context |
|---|---|
Relationships (1)
The New Leaf team is credited with managing the 'Sprout Funds' (Sprout Capital IX, VIII, VII, and Growth II).
Key Quotes (3)
"The Fund Managers’ long term track record in healthcare technology investing clearly establishes the team as one of the most successful in the venture capital industry over the last two decades."Source
HOUSE_OVERSIGHT_024029.jpg
Quote #1
"The New Leaf team has invested over $1.67 billion in 126 healthcare technology companies within 6 distinct funds since 1995."Source
HOUSE_OVERSIGHT_024029.jpg
Quote #2
"generating gross realizations of over $2.6 billion and a gross realized cash-on-cash return and internal rate of return (IRR) of 2.1x and 17%, respectively."Source
HOUSE_OVERSIGHT_024029.jpg
Quote #3
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein document